Sun Pharmaceutical Industries Inc has recalled 144 bottles of a generic anti-depression medicine from the US market due to a manufacturing issue, according to the U.S. Food and Drug Administration (FDA).

The U.S.-based subsdiary of the Mumbai-headquartered drug company initiated the recall for the affected lot of Bupropion Hydrochloride extended-release tablets due to “failed dissolution specifications,” the U.S. health regulator said in its latest Enforcement Report.

The affected lot was manufactured at Sun Pharma’s Halol-based plant in Gujarat and was distributed in the U.S. by Sun Pharmaceutical Industries Inc, based in Princeton, New Jersy, it said.

Bupropion is a medication commonly used to treat depression.

The U.S.-based drug maker initiated the voluntary Class III nationwide (US) recall on October 4 this year.